Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VATCH: Trametinib in Ras/MAPK Pathway Driven Vascular Anomalies
NCT07549646Phase 2Recruiting
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Aug 2025
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in vascular anomaly, sponsored by Children's Hospital of Philadelphia. Started Aug 2025; status: recruiting.
02
Drugs
trametinib
03
Conditions
vascular anomaly
Beyond the preview
Go deeper on NCT07549646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549646.